Catalyst Event
Giant Biogene Holding Co Ltd (2367) · Other
From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)
6/1/2026, 12:00:00 AM
Ex-dividend date on 2026-06-01 for a final dividend of RMB 0.5390 and a special dividend of RMB 0.6714 for FY2025, totaling RMB 1.2104 per share, scheduled. Medium importance is estimated based on the expected price adjustment on the ex-dividend date.
Korean Translation
2025 회계연도 기말 배당금 0.5390위안 및 특별 배당금 0.6714위안(총 1.2104위안)에 대한 2026-06-01 배당락일로 예정됨. 배당락에 따른 주가 조정을 고려하여 중요도를 'Medium'으로 추정함.
Related Recent Events
Eli Lilly and Co (LLY) · Earnings Release
Q2 2026 earnings release and conference call. Medium importance is estimated as earnings releases typically cause >5% price volatility scheduled.
8/5/2026, 12:00:00 AM
Boston Scientific Corp (BSX) · Earnings Release
The Q2 2026 earnings release scheduled for 2026-07-29, for which high importance is estimated due to typical market volatility surrounding quarterly results, is expected.
7/29/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Earnings Release
Q2 2026 earnings release is scheduled for July 16, 2026; a price impact of at least 5% is estimated based on historical volatility, scheduled.
7/16/2026, 12:00:00 AM
Hansoh Pharmaceutical Group Company Limited (3692) · Other
Final dividend of HKD 0.20 per share ex-dividend on July 3, 2026; standard corporate action with minor price adjustment scheduled.
7/3/2026, 12:00:00 AM
CSPC Pharmaceutical Group Ltd (1093) · Other
Ex-dividend date for the 2025 final dividend of HK$0.15 per share, which was announced on March 25, 2026. The payment date is July 15, 2026.
6/24/2026, 12:00:00 AM
Sonova Holding AG (SOON) · Other
Ex-dividend date (2026-06-19) for a proposed record-high annual dividend of CHF 4.70 per share; impact estimated at ~2% as dividend is record-high, scheduled.
6/19/2026, 12:00:00 AM